Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Amifostine for Radiochemotherapy-Induced Esophagitis in NSCLC
NCT00081315Phase 2Completed
- Sponsor
- MedImmune
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in esophagitis and pneumonitis comparing Amifostine with Placebo (2 arms). Primary endpoint: Acute radiochemotherapy-induced esophagitis. Started Nov 2003; status: completed.
02
Drugs
amifostine
03
Conditions
esophagitispneumonitis
Beyond the preview
Go deeper on NCT00081315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081315.